Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ITMCTR2026001046) titled 'A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Exploratory Clinical Trial on the Efficacy of Rapid-acting in the Treatment of Microvascular Angina' on April 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tianjin University of Traditional Chinese Medicine
Condition:
Microvascular angina
Intervention:
Experimental Group:Basic treatment for microvascular angina + Suxiao Jiuxin Wan. Take 6 pills of Suxiao Jiuxin Wan each time, 3 times a day, sublingual administration.
Recruitment Status: Not Recruiting
Phase: Pilot clinical trial
Date of First Enrollment: 2026-04...